EGFR and breast carcinoma: We have previously demonstrated via the WAP-TGFα transgenic mouse model that EGFR is colocalized with the oncogenic adaptor protein MUC1 in hyperplastic and tumor tissues and EGFR-driven breast cancer is largely MUC1-dependent [19].